ONCT Executive Compensation
* In USD (Original Currency)|
Filing Date (SEC Report) |
Year | Reporting Name | Salary | Bonus | Stock Award | Incentive Plan Compensation | Other Compensation | Total |
|---|---|---|---|---|---|---|---|---|
| 2023-05-16 | 2022 | James B. Breitmeyer, M.D., Ph.D. President & Chief Executive Officer | 579,873 | 0 | 505,444 | 222,600 | 12,200 | 2,407,905 |
| 2023-05-16 | 2021 | James B. Breitmeyer, M.D., Ph.D. President & Chief Executive Officer | 556,500 | 0 | 0 | 222,600 | 0 | 4,680,675 |
| 2023-05-16 | 2022 | Salim Yazji, M.D. Chief Medical Officer | 448,866 | 0 | 224,643 | 88,140 | 12,200 | 962,466 |
| 2023-05-16 | 2021 | Salim Yazji, M.D. Chief Medical Officer | 264,518 | 0 | 0 | 88,140 | 0 | 2,015,428 |
| 2023-05-16 | 2022 | Gunnar F. Kaufmann, Ph.D. | 415,948 | 0 | 117,427 | 132,788 | 0 | 941,210 |
| 2022-04-29 | 2021 | Salim Yazji, M.D. | 264,518 | 0 | 0 | 88,140 | 0 | 2,015,428 |
| 2022-04-29 | 2020 | James B. Breitmeyer, M.D., Ph.D. President & Chief Executive Officer | 530,000 | 1,000 | 0 | 249,100 | 0 | 780,100 |
| 2022-04-29 | 2021 | James B. Breitmeyer, M.D., Ph.D. President & Chief Executive Officer | 556,500 | 0 | 0 | 222,600 | 0 | 4,680,675 |
| 2022-04-29 | 2021 | Richard G. Vincent | 393,750 | 0 | 0 | 130,725 | 0 | 1,981,063 |
| 2021-04-13 | 2019 | James B. Breitmeyer, M.D., Ph.D. President and Chief Executive Officer | 501,588 | 0 | 0 | 225,250 | 0 | 1,115,838 |
| 2021-04-13 | 2019 | Frank J. Hsu, M.D. Former Chief Medical Officer | 139,583 | 0 | 0 | 42,643 | 18,417 | 769,143 |
| 2021-04-13 | 2020 | Frank J. Hsu, M.D. Former Chief Medical Officer | 400,000 | 1,000 | 0 | 133,760 | 20,960 | 555,720 |
| 2021-04-13 | 2019 | Gunnar F. Kaufmann, Ph.D. Chief Scientific Officer | 122,444 | 0 | 0 | 37,361 | 0 | 683,305 |
| 2021-04-13 | 2020 | Gunnar F. Kaufmann, Ph.D. Chief Scientific Officer | 380,000 | 1,000 | 0 | 143,184 | 1,702 | 525,886 |
| 2021-04-13 | 2020 | James B. Breitmeyer, M.D., Ph.D. President and Chief Executive Officer | 530,000 | 1,000 | 0 | 249,100 | 1,702 | 781,802 |
| 2020-04-29 | 2019 | Marc S. Hanover Former President and Chief Executive Officer | 213,130 | 0 | 0 | 0 | 445,628 | 658,759 |
| 2020-04-29 | 2018 | Marc S. Hanover Former President and Chief Executive Officer | 445,628 | 0 | 0 | 115,863 | 22,338 | 1,243,813 |
| 2020-04-29 | 2019 | Hazel M. Aker General Counsel | 150,000 | 0 | 0 | 59,020 | 20,700 | 813,220 |
| 2020-04-29 | 2018 | Hazel M. Aker General Counsel | 0 | 0 | 0 | 0 | 0 | 0 |
| 2020-04-29 | 2019 | Henry P. Doggrell Former Vice President, Chief Legal Officer and Secretary | 186,268 | 0 | 0 | 0 | 406,701 | 592,969 |
| 2020-04-29 | 2018 | Henry P. Doggrell Former Vice President, Chief Legal Officer and Secretary | 389,463 | 0 | 0 | 54,525 | 24,836 | 925,736 |
| 2020-04-29 | 2019 | Frank J. Hsu, M.D. Chief Medical Officer | 139,583 | 0 | 0 | 42,643 | 18,417 | 769,143 |
| 2020-04-29 | 2018 | Frank J. Hsu, M.D. Chief Medical Officer | 0 | 0 | 0 | 0 | 0 | 0 |
| 2020-04-29 | 2019 | James B. Breitmeyer, M.D., Ph.D. President and Chief Executive Officer | 501,588 | 0 | 0 | 225,250 | 0 | 1,115,838 |
| 2020-04-29 | 2018 | James B. Breitmeyer, M.D., Ph.D. President and Chief Executive Officer | 426,028 | 0 | 0 | 0 | 0 | 518,028 |
| 2018-03-23 | 2017 | Henry P. Doggrell Vice President, Chief Legal | 378,119 | 13,234 | 0 | 72,788 | 21,996 | 778,337 |
| 2018-03-23 | 2016 | Henry P. Doggrell Vice President, Chief Legal | 378,119 | 13,234 | 0 | 66,171 | 21,796 | 617,420 |
| 2018-03-23 | 2016 | Marc S. Hanover Chief Executive Officer | 432,649 | 28,122 | 0 | 140,611 | 19,392 | 841,734 |
| 2018-03-23 | 2017 | Marc S. Hanover Chief Executive Officer | 432,649 | 28,122 | 0 | 154,672 | 21,586 | 984,017 |
| 2018-03-23 | 2017 | Robert J. Wills Executive Chairman | 220,000 | 14,300 | 0 | 78,650 | 31,268 | 691,206 |
| 2018-03-23 | 2016 | Robert J. Wills Executive Chairman | 220,000 | 14,300 | 0 | 71,500 | 29,459 | 556,219 |
| 2017-03-31 | 2015 | Henry P. Doggrell Vice President, | 363,576 | 0 | 330,000 | 0 | 21,205 | 714,781 |
| 2017-03-31 | 2016 | Henry P. Doggrell Vice President, | 378,119 | 13,234 | 0 | 66,171 | 21,796 | 617,420 |
| 2017-03-31 | 2016 | Robert J. Wills Executive Chairman | 220,000 | 14,300 | 0 | 71,500 | 29,459 | 556,219 |
| 2017-03-31 | 2015 | Robert J. Wills Executive Chairman | 169,231 | 0 | 750,000 | 0 | 28,571 | 947,802 |
| 2017-03-31 | 2016 | Marc S. Hanover Chief Executive | 432,649 | 28,122 | 0 | 140,611 | 19,392 | 841,734 |
| 2017-03-31 | 2015 | Marc S. Hanover Chief Executive | 393,317 | 0 | 495,000 | 0 | 17,758 | 906,075 |
| 2016-03-28 | 2014 | Henry P. Doggrell Vice President, Chief Legal Officer and Secretary | 363,576 | 181,788 | 0 | 63,626 | 21,005 | 833,375 |
| 2016-03-28 | 2015 | Henry P. Doggrell Vice President, Chief Legal Officer and Secretary | 363,576 | 0 | 330,000 | 0 | 21,205 | 714,781 |
| 2016-03-28 | 2013 | Jason T. Shackelford Senior Director, Accounting and Corporate Controller | 178,010 | 0 | 94,000 | 0 | 7,115 | 437,064 |
| 2016-03-28 | 2015 | Marc S. Hanover Chief Executive Officer | 393,317 | 0 | 495,000 | 0 | 17,758 | 906,075 |
| 2016-03-28 | 2013 | Marc S. Hanover Chief Executive Officer | 466,685 | 0 | 0 | 0 | 21,442 | 741,009 |
| 2016-03-28 | 2014 | Marc S. Hanover Chief Executive Officer | 393,317 | 0 | 0 | 127,828 | 19,380 | 1,385,300 |
| 2016-03-28 | 2015 | Jason T. Shackelford Senior Director, Accounting and Corporate Controller | 210,000 | 0 | 198,000 | 0 | 9,450 | 417,450 |
| 2016-03-28 | 2014 | Jason T. Shackelford Senior Director, Accounting and Corporate Controller | 199,365 | 89,005 | 0 | 26,250 | 10,400 | 515,978 |
| 2016-03-28 | 2015 | Diane C. Young, M.D. | 84,135 | 0 | 705,000 | 0 | 11,798 | 800,933 |
| 2016-03-28 | 2015 | Robert J. Wills | 169,231 | 0 | 750,000 | 0 | 28,571 | 947,802 |
| 2016-03-28 | 2013 | Henry P. Doggrell Vice President, Chief Legal Officer and Secretary | 363,576 | 0 | 188,000 | 0 | 23,469 | 865,634 |
| 2015-03-26 | 2013 | James T. Dalton, Ph.D. Former Vice President, Chief Scientific Officer | 416,456 | 0 | 188,000 | 0 | 18,636 | 913,681 |
| 2015-03-26 | 2014 | Marc S. Hanover Chief Executive Officer | 393,317 | 0 | 0 | 127,828 | 19,380 | 1,385,300 |
| 2015-03-26 | 2013 | Marc S. Hanover Chief Executive Officer | 466,685 | 0 | 0 | 0 | 21,442 | 741,009 |
| 2015-03-26 | 2012 | Marc S. Hanover Chief Executive Officer | 475,020 | 0 | 0 | 151,531 | 20,115 | 796,284 |
| 2015-03-26 | 2014 | Mitchell S. Steiner, M.D., F.A.C.S. Former Chief Executive Officer | 139,104 | 0 | 0 | 0 | 488,887 | 986,639 |
| 2015-03-26 | 2013 | Mitchell S. Steiner, M.D., F.A.C.S. Former Chief Executive Officer | 536,420 | 0 | 0 | 0 | 15,692 | 931,435 |
| 2015-03-26 | 2012 | Mitchell S. Steiner, M.D., F.A.C.S. Former Chief Executive Officer | 546,000 | 0 | 0 | 205,842 | 13,771 | 990,040 |
| 2015-03-26 | 2014 | Jason T. Shackelford | 199,365 | 89,005 | 0 | 26,250 | 10,400 | 515,978 |
| 2015-03-26 | 2012 | James T. Dalton, Ph.D. Former Vice President, Chief Scientific Officer | 416,000 | 0 | 0 | 72,384 | 17,992 | 581,185 |
| 2015-03-26 | 2014 | James T. Dalton, Ph.D. Former Vice President, Chief Scientific Officer | 249,519 | 187,500 | 0 | 0 | 41,256 | 489,694 |
| 2015-03-26 | 2012 | Henry P. Doggrell Vice President, Chief Legal Officer and Secretary | 351,281 | 0 | 0 | 61,123 | 19,719 | 506,932 |
| 2015-03-26 | 2013 | Henry P. Doggrell Vice President, Chief Legal Officer and Secretary | 363,576 | 0 | 188,000 | 0 | 23,469 | 865,634 |
| 2015-03-26 | 2014 | Henry P. Doggrell Vice President, Chief Legal Officer and Secretary | 363,576 | 181,788 | 0 | 63,626 | 21,005 | 833,375 |
| 2014-03-24 | 2013 | Marc S. Hanover President, Chief Operating Officer and acting Principal Financial Officer | 466,685 | 0 | 0 | 0 | 21,442 | 741,009 |
| 2014-03-24 | 2011 | Mitchell S. Steiner, M.D., F.A.C.S. Chief Executive Officer and Vice- Chairman of the Board of Directors | 525,000 | 170,625 | 0 | 0 | 10,030 | 879,619 |
| 2014-03-24 | 2012 | Mitchell S. Steiner, M.D., F.A.C.S. Chief Executive Officer and Vice- Chairman of the Board of Directors | 546,000 | 0 | 0 | 205,842 | 13,771 | 990,040 |
| 2014-03-24 | 2013 | Mitchell S. Steiner, M.D., F.A.C.S. Chief Executive Officer and Vice- Chairman of the Board of Directors | 536,420 | 0 | 0 | 0 | 15,692 | 931,435 |
| 2014-03-24 | 2012 | James T. Dalton, Ph.D. Vice President, Chief Scientific Officer | 416,000 | 0 | 0 | 72,384 | 17,992 | 581,185 |
| 2014-03-24 | 2013 | James T. Dalton, Ph.D. Vice President, Chief Scientific Officer | 416,456 | 0 | 188,000 | 0 | 18,636 | 913,681 |
| 2014-03-24 | 2011 | James T. Dalton, Ph.D. Vice President, Chief Scientific Officer | 400,000 | 60,000 | 0 | 0 | 15,840 | 558,680 |
| 2014-03-24 | 2013 | Henry P. Doggrell Vice President, Chief Legal Officer and Secretary | 363,576 | 0 | 188,000 | 0 | 23,469 | 865,634 |
| 2014-03-24 | 2012 | Henry P. Doggrell Vice President, Chief Legal Officer and Secretary | 351,281 | 0 | 0 | 61,123 | 19,719 | 506,932 |
| 2014-03-24 | 2011 | Henry P. Doggrell Vice President, Chief Legal Officer and Secretary | 343,589 | 52,962 | 0 | 0 | 18,974 | 473,513 |
| 2014-03-24 | 2011 | Mark E. Mosteller, CPA Former Vice President, Chief Financial Officer and Treasurer | 298,083 | 44,712 | 0 | 0 | 12,910 | 413,693 |
| 2014-03-24 | 2012 | Mark E. Mosteller, CPA Former Vice President, Chief Financial Officer and Treasurer | 310,006 | 0 | 0 | 53,941 | 14,050 | 452,806 |
| 2014-03-24 | 2013 | Mark E. Mosteller, CPA Former Vice President, Chief Financial Officer and Treasurer | 320,857 | 0 | 0 | 0 | 276,729 | 878,285 |
| 2014-03-24 | 2011 | Marc S. Hanover President, Chief Operating Officer and acting Principal Financial Officer | 456,750 | 125,606 | 0 | 0 | 18,389 | 716,721 |
| 2014-03-24 | 2012 | Marc S. Hanover President, Chief Operating Officer and acting Principal Financial Officer | 475,020 | 0 | 0 | 151,531 | 20,115 | 796,284 |
| 2013-03-15 | 2010 | Marc S. Hanover President and Chief Operating Officer | 456,750 | 0 | 0 | 0 | 18,389 | 661,332 |
| 2013-03-15 | 2012 | Mitchell S. Steiner, M.D., F.A.C.S. Chief Executive Officer and Vice- Chairman of the Board of Directors | 546,000 | 0 | 0 | 205,842 | 13,771 | 990,040 |
| 2013-03-15 | 2011 | Mitchell S. Steiner, M.D., F.A.C.S. Chief Executive Officer and Vice- Chairman of the Board of Directors | 525,000 | 170,625 | 0 | 0 | 10,030 | 879,619 |
| 2013-03-15 | 2010 | Mitchell S. Steiner, M.D., F.A.C.S. Chief Executive Officer and Vice- Chairman of the Board of Directors | 525,000 | 0 | 0 | 0 | 10,030 | 814,320 |
| 2013-03-15 | 2012 | Mark E. Mosteller, CPA Vice President, Chief Financial Officer and Treasurer | 310,006 | 0 | 0 | 53,941 | 14,050 | 452,806 |
| 2013-03-15 | 2010 | James T. Dalton, Ph.D. Vice President, Chief Scientific Officer | 400,000 | 0 | 0 | 0 | 16,409 | 509,506 |
| 2013-03-15 | 2011 | James T. Dalton, Ph.D. Vice President, Chief Scientific Officer | 400,000 | 60,000 | 0 | 0 | 15,840 | 558,680 |
| 2013-03-15 | 2012 | Henry P. Doggrell | 351,281 | 0 | 0 | 61,123 | 19,719 | 506,932 |
| 2013-03-15 | 2011 | Mark E. Mosteller, CPA Vice President, Chief Financial Officer and Treasurer | 298,083 | 44,712 | 0 | 0 | 12,910 | 413,693 |
| 2013-03-15 | 2010 | Mark E. Mosteller, CPA Vice President, Chief Financial Officer and Treasurer | 298,083 | 0 | 0 | 0 | 12,910 | 404,090 |
| 2013-03-15 | 2012 | Marc S. Hanover President and Chief Operating Officer | 475,020 | 0 | 0 | 151,531 | 20,115 | 796,284 |
| 2013-03-15 | 2011 | Marc S. Hanover President and Chief Operating Officer | 456,750 | 125,606 | 0 | 0 | 18,389 | 716,721 |
| 2013-03-15 | 2012 | James T. Dalton, Ph.D. Vice President, Chief Scientific Officer | 416,000 | 0 | 0 | 72,384 | 17,992 | 581,185 |
| 2012-03-12 | 2011 | James T. Dalton, Ph.D. Vice President, Chief Scientific Officer Gregory A. Deener Former Vice President, Sales and Marketing | 128,496 | 0 | 0 | 0 | 134,696 | 680,128 |
| 2011-03-18 | 2009 | Mark E. Mosteller, CPA Vice President, Chief Financial Officer and Treasurer | 298,083 | 0 | 0 | 0 | 0 | 545,218 |
| 2011-03-18 | 2010 | Mark E. Mosteller, CPA Vice President, Chief Financial Officer and Treasurer | 298,083 | 0 | 0 | 0 | 0 | 404,090 |
| 2011-03-18 | 2008 | Mitchell S. Steiner, M.D., F.A.C.S. Chief Executive Officer and Vice-Chairman of the Board of Directors | 500,000 | 0 | 0 | 0 | 0 | 710,967 |
| 2011-03-18 | 2009 | Mitchell S. Steiner, M.D., F.A.C.S. Chief Executive Officer and Vice-Chairman of the Board of Directors | 525,000 | 0 | 0 | 0 | 0 | 1,236,793 |
| 2011-03-18 | 2008 | James T. Dalton, Ph.D. Vice President, Preclinical Research and Development | 311,875 | 0 | 0 | 0 | 0 | 632,775 |
| 2011-03-18 | 2009 | James T. Dalton, Ph.D. Vice President, Preclinical Research and Development | 400,000 | 0 | 0 | 0 | 0 | 689,165 |
| 2011-03-18 | 2010 | James T. Dalton, Ph.D. Vice President, Preclinical Research and Development | 400,000 | 0 | 0 | 0 | 0 | 509,506 |
| 2011-03-18 | 2008 | Ronald A. Morton, Jr., M.D., F.A.C.S. Vice President, Chief Medical Officer | 430,500 | 28,000 | 0 | 0 | 0 | 794,226 |
| 2011-03-18 | 2009 | Ronald A. Morton, Jr., M.D., F.A.C.S. Vice President, Chief Medical Officer | 452,025 | 0 | 0 | 0 | 0 | 716,684 |
| 2011-03-18 | 2010 | Ronald A. Morton, Jr., M.D., F.A.C.S. Vice President, Chief Medical Officer | 452,025 | 0 | 0 | 0 | 0 | 577,342 |
| 2011-03-18 | 2008 | Marc S. Hanover President and Chief Operating Officer | 435,000 | 0 | 0 | 0 | 0 | 1,609,564 |
| 2011-03-18 | 2009 | Marc S. Hanover President and Chief Operating Officer | 456,750 | 0 | 0 | 0 | 0 | 943,589 |
| 2011-03-18 | 2010 | Mitchell S. Steiner, M.D., F.A.C.S. Chief Executive Officer and Vice-Chairman of the Board of Directors | 525,000 | 0 | 0 | 0 | 0 | 814,320 |
| 2011-03-18 | 2008 | Mark E. Mosteller, CPA Vice President, Chief Financial Officer and Treasurer | 283,889 | 0 | 0 | 0 | 0 | 566,666 |
| 2011-03-18 | 2010 | Marc S. Hanover President and Chief Operating Officer | 456,750 | 0 | 0 | 0 | 0 | 661,332 |
| 2010-03-18 | 2009 | Ronald A. Morton, Jr., M.D., F.A.C.S. Vice President, Chief Medical Officer | 452,025 | 0 | 0 | 0 | 0 | 716,684 |
| 2010-03-18 | 2007 | Ronald A. Morton, Jr., M.D., F.A.C.S. Vice President, Chief Medical Officer | 294,885 | 0 | 0 | 0 | 0 | 1,222,574 |
| 2010-03-18 | 2009 | James T. Dalton, Ph.D. Vice President, Preclinical Research and Development | 400,000 | 0 | 0 | 0 | 0 | 689,165 |
| 2010-03-18 | 2008 | James T. Dalton, Ph.D. Vice President, Preclinical Research and Development | 311,875 | 0 | 0 | 0 | 0 | 632,775 |
| 2010-03-18 | 2007 | James T. Dalton, Ph.D. Vice President, Preclinical Research and Development | 260,000 | 0 | 0 | 0 | 0 | 586,007 |
| 2010-03-18 | 2009 | Mitchell S. Steiner, M.D., F.A.C.S. Chief Executive Officer and Vice-Chairman of the Board of Directors | 525,000 | 0 | 0 | 0 | 0 | 1,236,793 |
| 2010-03-18 | 2008 | Mitchell S. Steiner, M.D., F.A.C.S. Chief Executive Officer and Vice-Chairman of the Board of Directors | 500,000 | 0 | 0 | 0 | 0 | 710,967 |
| 2010-03-18 | 2007 | Mitchell S. Steiner, M.D., F.A.C.S. Chief Executive Officer and Vice-Chairman of the Board of Directors | 446,250 | 0 | 0 | 0 | 0 | 579,794 |
| 2010-03-18 | 2009 | Mark E. Mosteller, CPA Vice President, Chief Financial Officer and Treasurer | 298,083 | 0 | 0 | 0 | 0 | 545,218 |
| 2010-03-18 | 2008 | Mark E. Mosteller, CPA Vice President, Chief Financial Officer and Treasurer | 283,889 | 0 | 0 | 0 | 0 | 566,666 |
| 2010-03-18 | 2007 | Mark E. Mosteller, CPA Vice President, Chief Financial Officer and Treasurer | 246,750 | 0 | 0 | 0 | 0 | 580,487 |
| 2010-03-18 | 2009 | Marc S. Hanover President and Chief Operating Officer | 456,750 | 0 | 0 | 0 | 0 | 943,589 |
| 2010-03-18 | 2008 | Marc S. Hanover President and Chief Operating Officer | 435,000 | 0 | 0 | 0 | 0 | 1,609,564 |
| 2010-03-18 | 2007 | Marc S. Hanover President and Chief Operating Officer | 306,600 | 0 | 0 | 0 | 0 | 394,207 |
| 2010-03-18 | 2008 | Ronald A. Morton, Jr., M.D., F.A.C.S. Vice President, Chief Medical Officer | 430,500 | 28,000 | 0 | 0 | 0 | 794,226 |
| 2009-03-20 | 2006 | James T. Dalton, Ph.D. Vice President, Preclinical Research and Development | 241,772 | 0 | 0 | 0 | 24,278 | 347,597 |
| 2009-03-20 | 2007 | James T. Dalton, Ph.D. Vice President, Preclinical Research and Development | 260,000 | 0 | 0 | 59,280 | 8,839 | 449,759 |
| 2009-03-20 | 2008 | James T. Dalton, Ph.D. Vice President, Preclinical Research and Development | 311,875 | 0 | 0 | 77,189 | 43,088 | 594,348 |
| 2009-03-20 | 2006 | Ronald A. Morton, Jr., M.D., F.A.C.S. Vice President, Chief Medical Officer | 0 | 0 | 0 | 0 | 0 | 0 |
| 2009-03-20 | 2007 | Ronald A. Morton, Jr., M.D., F.A.C.S. Vice President, Chief Medical Officer | 294,885 | 0 | 0 | 71,094 | 20,397 | 498,052 |
| 2009-03-20 | 2008 | Ronald A. Morton, Jr., M.D., F.A.C.S. Vice President, Chief Medical Officer | 430,500 | 28,000 | 0 | 105,903 | 29,200 | 801,198 |
| 2009-03-20 | 2006 | Marc S. Hanover President and Chief Operating Officer | 293,891 | 30,660 | 0 | 0 | 495 | 325,046 |
| 2009-03-20 | 2007 | Marc S. Hanover President and Chief Operating Officer | 306,600 | 0 | 0 | 77,263 | 10,344 | 394,207 |
| 2009-03-20 | 2008 | Marc S. Hanover President and Chief Operating Officer | 435,000 | 0 | 0 | 158,558 | 12,893 | 806,854 |
| 2009-03-20 | 2006 | Mark E. Mosteller, CPA Vice President, Chief Financial Officer and Treasurer | 236,692 | 12,338 | 0 | 0 | 3,941 | 382,470 |
| 2009-03-20 | 2007 | Mark E. Mosteller, CPA Vice President, Chief Financial Officer and Treasurer | 246,750 | 0 | 0 | 66,623 | 9,226 | 490,883 |
| 2009-03-20 | 2008 | Mark E. Mosteller, CPA Vice President, Chief Financial Officer and Treasurer | 283,889 | 0 | 0 | 70,263 | 11,891 | 574,412 |
| 2009-03-20 | 2006 | Mitchell S. Steiner, M.D., F.A.C.S. Chief Executive Officer and Vice-Chairman of the Board of Directors | 427,055 | 44,625 | 0 | 0 | 653 | 472,333 |
| 2009-03-20 | 2007 | Mitchell S. Steiner, M.D., F.A.C.S. Chief Executive Officer and Vice-Chairman of the Board of Directors | 446,250 | 0 | 0 | 128,520 | 5,024 | 579,794 |
| 2009-03-20 | 2008 | Mitchell S. Steiner, M.D., F.A.C.S. Chief Executive Officer and Vice-Chairman of the Board of Directors | 500,000 | 0 | 0 | 202,500 | 8,467 | 710,967 |
| 2008-03-12 | 2007 | Marc S. Hanover President and Chief Operating Officer | 306,600 | 0 | 0 | 0 | 0 | 394,207 |
| 2008-03-12 | 2007 | Ronald A. Morton, Jr., M.D., F.A.C.S. | 294,885 | 0 | 0 | 0 | 0 | 498,052 |
| 2008-03-12 | 2006 | Ronald A. Morton, Jr., M.D., F.A.C.S. | 0 | 0 | 0 | 0 | 0 | 0 |
| 2008-03-12 | 2007 | Henry P. Doggrell Vice President, General Counsel and Secretary | 265,650 | 0 | 0 | 0 | 0 | 458,940 |
| 2008-03-12 | 2006 | Henry P. Doggrell Vice President, General Counsel and Secretary | 254,835 | 13,283 | 0 | 0 | 0 | 371,832 |
| 2008-03-12 | 2006 | Mark E. Mosteller, CPA Vice President, Chief Financial Officer and Treasurer | 236,692 | 12,338 | 0 | 0 | 0 | 378,935 |
| 2008-03-12 | 2007 | Mitchell S. Steiner, M.D., F.A.C.S. | 446,250 | 0 | 0 | 0 | 0 | 579,794 |
| 2008-03-12 | 2006 | Mitchell S. Steiner, M.D., F.A.C.S. | 427,055 | 44,625 | 0 | 0 | 0 | 472,333 |
| 2008-03-12 | 2007 | Mark E. Mosteller, CPA Vice President, Chief Financial Officer and Treasurer | 246,750 | 0 | 0 | 0 | 0 | 490,883 |
| 2008-03-12 | 2006 | Marc S. Hanover President and Chief Operating Officer | 293,891 | 30,660 | 0 | 0 | 0 | 325,046 |
| 2007-03-14 | 2006 | Mark E. Mosteller, CPA | 236,692 | 12,338 | 0 | 0 | 406 | 378,935 |
| 2007-03-14 | 2006 | Marc S. Hanover | 293,891 | 30,660 | 0 | 0 | 495 | 325,046 |
| 2007-03-14 | 2006 | James T. Dalton, Ph.D. | 241,772 | 0 | 0 | 0 | 20,414 | 343,733 |
| 2007-03-14 | 2006 | Henry P. Doggrell | 254,835 | 13,283 | 0 | 0 | 423 | 371,832 |
| 2007-03-14 | 2006 | Mitchell S. Steiner, M.D., F.A.C.S. | 427,055 | 44,625 | 0 | 0 | 653 | 472,333 |
| 2006-03-08 | 2005 | Mitchell S. Steiner, M.D., F.A.C.S. Chief Executive Officer and Vice-Chairman of the Board of Directors | 390,507 | 0 | 0 | 0 | 0 | 390,507 |
| 2006-03-08 | 2003 | James T. Dalton, Ph.D. Vice President, Preclinical Research and Development | 0 | 0 | 0 | 0 | 24,000 | 24,000 |
| 2006-03-08 | 2005 | Henry P. Doggrell Vice President, General Counsel and Secretary | 235,514 | 0 | 0 | 0 | 0 | 235,514 |
| 2006-03-08 | 2003 | Marc S. Hanover President and Chief Operating Officer | 180,000 | 0 | 0 | 0 | 0 | 180,000 |
| 2006-03-08 | 2004 | Marc S. Hanover President and Chief Operating Officer | 215,000 | 0 | 0 | 0 | 0 | 215,000 |
| 2006-03-08 | 2005 | Marc S. Hanover President and Chief Operating Officer | 263,033 | 0 | 0 | 0 | 0 | 263,033 |
| 2006-03-08 | 2003 | Mitchell S. Steiner, M.D., F.A.C.S. Chief Executive Officer and Vice-Chairman of the Board of Directors | 311,666 | 0 | 0 | 0 | 0 | 311,666 |
| 2006-03-08 | 2004 | James T. Dalton, Ph.D. Vice President, Preclinical Research and Development | 0 | 0 | 0 | 0 | 24,000 | 24,000 |
| 2006-03-08 | 2005 | James T. Dalton, Ph.D. Vice President, Preclinical Research and Development | 231,945 | 50,000 | 0 | 0 | 0 | 281,945 |
| 2006-03-08 | 2003 | K. Gary Barnette, Ph.D. Vice President, Clinical Research and Development Strategy | 172,629 | 0 | 0 | 0 | 0 | 172,629 |
| 2006-03-08 | 2004 | K. Gary Barnette, Ph.D. Vice President, Clinical Research and Development Strategy | 190,000 | 0 | 0 | 0 | 0 | 190,000 |
| 2006-03-08 | 2005 | K. Gary Barnette, Ph.D. Vice President, Clinical Research and Development Strategy | 225,438 | 0 | 0 | 0 | 0 | 225,438 |
| 2006-03-08 | 2003 | Henry P. Doggrell Vice President, General Counsel and Secretary | 193,000 | 0 | 0 | 0 | 0 | 193,000 |
| 2006-03-08 | 2004 | Henry P. Doggrell Vice President, General Counsel and Secretary | 211,583 | 0 | 0 | 0 | 0 | 211,583 |
| 2006-03-08 | 2004 | Mitchell S. Steiner, M.D., F.A.C.S. Chief Executive Officer and Vice-Chairman of the Board of Directors | 375,000 | 0 | 0 | 0 | 0 | 375,000 |
| 2005-03-28 | 2004 | Henry P. Doggrell Vice President, General Counsel and Secretary | 211,583 | 0 | 0 | 0 | 0 | 211,583 |
| 2005-03-28 | 2002 | Marc S. Hanover President and Chief Operating Officer | 180,000 | 0 | 0 | 0 | 0 | 180,000 |
| 2005-03-28 | 2003 | Marc S. Hanover President and Chief Operating Officer | 180,000 | 0 | 0 | 0 | 0 | 180,000 |
| 2005-03-28 | 2004 | Marc S. Hanover President and Chief Operating Officer | 215,000 | 0 | 0 | 0 | 0 | 215,000 |
| 2005-03-28 | 2002 | Mitchell S. Steiner, M.D., F.A.C.S. Chief Executive Officer and Vice-Chairman of the Board of Directors | 175,000 | 0 | 0 | 0 | 0 | 175,000 |
| 2005-03-28 | 2003 | Mitchell S. Steiner, M.D., F.A.C.S. Chief Executive Officer and Vice-Chairman of the Board of Directors | 311,666 | 0 | 0 | 0 | 0 | 311,666 |
| 2005-03-28 | 2002 | Mark E. Mosteller Vice President and Chief Financial Officer | 135,417 | 0 | 0 | 0 | 0 | 135,417 |
| 2005-03-28 | 2004 | Mitchell S. Steiner, M.D., F.A.C.S. Chief Executive Officer and Vice-Chairman of the Board of Directors | 375,000 | 0 | 0 | 0 | 0 | 375,000 |
| 2005-03-28 | 2003 | Henry P. Doggrell Vice President, General Counsel and Secretary | 193,000 | 0 | 0 | 0 | 0 | 193,000 |
| 2005-03-28 | 2002 | Henry P. Doggrell Vice President, General Counsel and Secretary | 178,750 | 0 | 0 | 0 | 0 | 178,750 |
| 2005-03-28 | 2004 | Mark E. Mosteller Vice President and Chief Financial Officer | 174,583 | 0 | 0 | 0 | 0 | 174,583 |
| 2005-03-28 | 2003 | Mark E. Mosteller Vice President and Chief Financial Officer | 154,167 | 0 | 0 | 0 | 0 | 154,167 |
Disclaimer: The data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by our third party API www.financialmodellingprep.com, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore, Discounting Cash Flows Inc. doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Discounting Cash Flows Inc. or anyone involved with Discounting Cash Flows Inc. will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
